Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)

Nigeria flag Nigeria · Delayed Price · Currency is NGN
9.25
+0.25 (2.78%)
At close: Apr 28, 2026
232.73%
Market Cap 38.46B
Revenue (ttm) 7.37B
Net Income (ttm) 976.42M
Shares Out 4.27B
EPS (ttm) 0.23
PE Ratio 39.39
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 833,143
Average Volume 1,826,852
Open 9.25
Previous Close 9.00
Day's Range 9.25 - 9.25
52-Week Range 2.60 - 16.15
Beta 0.85
RSI 43.71
Earnings Date Apr 28, 2026

About NGX:NEIMETH

Neimeth International Pharmaceuticals Plc manufactures and markets pharmaceutical and animal health products in Nigeria and Ghana. It provides health care, ethical, and veterinary related products; and poultry and animal range of anthelmintic products, as well as production enhancing medicaments. The company was formerly known as Pfizer Inc. and changed its name to Neimeth International Pharmaceuticals Plc. In 1997. Neimeth International Pharmaceuticals Plc was incorporated in 1957 and is based in Lagos, Nigeria. [Read more]

Industry Pharmaceutical Preparations
Founded 1957
Employees 216
Stock Exchange Nigerian Stock Exchange
Ticker Symbol NEIMETH
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.